Literature DB >> 30962017

Predictive factors of prostate cancer diagnosis with PSA 4.0-10.0 ng/ml in a multi-ethnic Asian population, Malaysia.

Raymond Shi Liang Yii1, Jasmine Lim1, Selvalingam Sothilingam1, Wei Sien Yeoh1, Ahmad Nazran Fadzli1, Teng Aik Ong1, Shanggar Kuppusamy1, Azad Hassan Abdul Razack2.   

Abstract

OBJECTIVES: To identify the associated factors determining prostate cancer detection using transrectal ultrasound (TRUS)-guided prostate biopsy, within a multi-ethnic Malaysian population with prostate specific antigen (PSA) between 4.0 and 10.0 ng/ml.
METHODS: Study subjects included men with initial PSA between 4.0 and 10.0 ng/ml that have undergone 12-core TRUS-guided prostate biopsy between 2009 and 2016. The prostate cancer detection rate was calculated, while potential factors associated with detection were investigated via univariable and multivariable analysis.
RESULTS: A total of 617 men from a multi-ethnic background encompassing Chinese (63.5%), Malay (23.1%) and Indian (13.3%) were studied. The overall cancer detection rate was 14.3% (88/617), which included cancers detected at biopsy 1 (first biopsy), biopsy 2 (second biopsy with previous negative biopsy) and biopsy ≥ 3 (third or more biopsies with prior negative biopsies). Indian men displayed higher detection rate (23.2%) and increased risk of prostate cancer development (OR 1.85, 95% CI 1.03-3.32, p < 0.05), compared to their Malay (9.8%) and Chinese (14.0%) counterparts. Multivariable analysis revealed that ethnicity and PSA density (PSAD) are independent factors associated with overall prostate cancer detection rate. A unit increase of PSAD reflected an increase in PSA after controlling for prostate volume.
CONCLUSION: Prostate cancer detection in Malaysia is comparatively lower. Our study suggests that ethnicity and PSA density should be considered when recommending first or repeat TRUS-guided prostate biopsy for prostate cancer detection in a multi-ethnic Malaysian population.
Copyright © 2019. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  Prostate cancer; Prostate specific antigen (PSA); Prostate volume; Transrectal ultrasound (TRUS)-Guided biopsy

Year:  2019        PMID: 30962017     DOI: 10.1016/j.asjsur.2019.02.014

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  1 in total

1.  Low reduction of prostate volume is a significant predictor of prostate cancer at subsequent biopsy in patients with dutasteride: A retrospective study.

Authors:  Daisuke Obinata; Shugo Suzuki; Yataro Yamanaka; Tsuyoshi Yoshizawa; Junichi Mochida; Kenya Yamaguchi; Satoru Takahashi
Journal:  Andrologia       Date:  2020-08-20       Impact factor: 2.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.